Yiping Yang, MD, PhD

Director, Division of Hematology, @OhioState, @OSUCCC_James; Professor of Medicine, #cancerimmunology, #immunotherapy, #Tcells, #NKcells, #leukemia, #lymphoma

[Pelotonia Institute for Immuno-Oncology @OhioStatePIIO]

Dr. @YipingYangMD speaks about the use of CAR T-cell therapy to turn a patient’s own blood into a cancer-fighting weapon in this Ohio State Health & Discovery article. https://t.co/qTMIfnvUok #cancerimmunology, #immunotherapy, #Tcells, #NKcells, #leukemia, #lymphoma

[Ohio State Hematology @OSUHematology]

Countdown to @ASH_hematology Review 2022 this Friday, January 21. There is still time to register: https://t.co/7KBUMhjgOX @OSUCCC_James @OSUWexMed

[Yiping Yang, MD, PhD @YipingYangMD]

2021 OSU Hematology Symposium @OSUCCC_James @OSUWexMed – What a success! Special thanks to the Symposium organizers – Drs. Kami Maddocks, Ashley Rosko, and Jennifer Woyach, as well as our faculty speakers and everyone involved! Very proud of them! @Kmaddmd @ashley_Rosko1

[Yiping Yang, MD, PhD @YipingYangMD]

Great success! 2020 OSU Hematology Symposium
@OSUCCC_James @OSUWexMed . Special thanks to Drs. Kami Maddocks, Ashley Rosko, Jennifer Woyach and team, and our keynote speaker, Dr. Sandeep Dave from Duke University. @kmaddmd @Ashley_Rosko1

[Ashley Rosko @Ashley_Rosko1]

#OSUHematology LEGEND Dr Rob Baiocchi !!🩸👏 🩸👏 @GretchenMcnally @kmaddmd @YipingYangMD

[Mark Bustoros @MarkBustoros]

Finally, our paper on Genomic Profiling of Smoldering Multiple Myeloma is out @JCO @ASCO_pubs! A work that took more than 3 years but with amazing collaborations led to this large study on smoldering multiple myeloma #SMM #mmsm https://t.co/Utv3QoYB0K

[Immunity @ImmunityCP]

Online now: Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity https://t.co/qiVKB4n3n3

[ASH @ASH_hematology]

As the #COVID19 pandemic continues, patient lives depend on the global community urgently coming together to share their experiences. Use the new @ASHCollab COVID-19 Registry to submit your data today https://t.co/LqnBy56O5I #ASHCOVID

[The James at Ohio State @OSUCCC_James]

Our chief medical officer shares important information for cancer patients during this unprecedented time.

[The James at Ohio State @OSUCCC_James]

On #InternationalWomensDay, we honor the late Dr. Clara Bloomfield, a groundbreaking blood #cancer researcher, and a former director of the OSUCCC. Learn more about Dr. Bloomfield's extraordinary career: https://t.co/ZwqE1RsfBe

[Dr Lynn O'Donnell @lynn_odonnell]

@BMTCTN does many great things for TCT patients and community. @OSUCCC_James is a big part of that. Congratulations OSU’s Rachel Dalton on being The Outstanding BMTCTN Coordinator of the Year! @Zihai @YipingYangMD Pass it on. #TCTM20

[Dr Lynn O'Donnell @lynn_odonnell]

To the Next Generation of transplant and cell therapy professionals: Check out the Career Board at #TCTM20. The ⁦@OSUCCC_James⁩ is looking for an Asst Dir of our CTx Production Facility. Alt: scan QR’s or go to ASTCT Job Connection. #SuccessionPlanning

[Yiping Yang, MD, PhD @YipingYangMD]

What a success - 2020 ASH Review organized by Division of Hematology @OhioState @OSUCCC_James. Special thanks to Drs. Walsh and Benson as well as our faculty speakers and everyone involved for making this a successful annual event! @Kathy_WalshMD

[Zihai Li, MD, PhD @Zihai]

Our story on #thrombin-mediated cleavage of #GARP to activate #TGFβ is out, supporting targeting GARP in #cancer #immunotherapy. Many thanks to all of the authors and collaborators for making it possible. @OSUCCC_James @muschollings @Pelotonia @ScienceTM
https://t.co/asLlMwZ5Ef

[Yiping Yang, MD, PhD @YipingYangMD]

Very proud that Division of Hematology faculty @OhioState @OSUCCC_James, delivered an outstanding program, chaired by Dr. Epperla, on state-of-the-art treatment strategies for leukemia, lymphoma and myeloma. Thank you! Drs. Brammer, Chaudhry, Epperla, Mims, and Woyach.

[OncLive SOSS @OncLiveSOSS]

That’s a wrap on our 2019 #stateofscience summits. Thank you to the wonderful faculty of @OSUCCC_James for helping us end the year on such a high note. To check out the list of 2020 programs in your area go to 👉https://t.co/EjfCdxAK3v

[Yiping Yang, MD, PhD @YipingYangMD]

Division of Hematology @OhioState @OSUCCC_James is represented by 54 abstracts that were accepted for display and 11 oral presentations at this year’s ASH annual meeting @ASH_hematology. We are very proud and believe this reflects the depth and diversity of our research program!

[Nature Portfolio @NaturePortfolio]

A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a study published in Nature. https://t.co/gNaL6CUNpb

[Yiping Yang, MD, PhD @YipingYangMD]

Hematologic malignancies and aging: our own Dr. Rosko @Ashley_Rosko1 is organizing a workshop on Hematology and Aging at the ASH conference next week!

[Ashley Rosko @Ashley_Rosko1]

It’s time...I know you are #ASH19 planning. Join us Friday for the Hematology and Aging Scientific Workshop co-chairing with ⁦⁦@ROlinMD⁩ #gerihem

[ASH @ASH_hematology]

Attend the Women in Hematology networking reception at #ASH19 & recognize the impact of women in our field https://t.co/ktJyCYHnZt #SHEmatology

[Yiping Yang, MD, PhD @YipingYangMD]

Dr. Carl June is delivering a talk on the design of the next generation CARs @ the inaugural #PIIO symposium @OSUCCC_James @OhioState @Zihai @carlhjune